Key Highlights
- NBIS shares climbed approximately 8.95% during trading, reaching a 52-week peak of $179.96
- The company announced plans to purchase Eigen AI for roughly $643 million to enhance its Token Factory AI capabilities
- Meta’s $27 billion partnership agreement elevated total contracted backlog close to $50 billion
- Goldman Sachs upgraded its price target post-Meta announcement; analyst consensus remains “Moderate Buy” with $154.75 average projection
- Next earnings report scheduled for May 13, focusing on Q1 2026 results with emphasis on ARR metrics and Eigen integration updates
Shares of Nebius Group (NBIS) kicked off Wednesday’s session at $175.92, climbing to a 52-week peak of $179.96 and posting gains close to 9% intraday. The stock has surged more than 110% since the beginning of the year.
The impressive rally follows two significant developments announced in quick succession — the company’s $643 million agreement to purchase Eigen AI and a substantial $27 billion partnership with Meta.
The strategic acquisition of Eigen AI aims to integrate advanced model-optimization and inference technology into Nebius’s Token Factory ecosystem. Industry analysts believe this transaction could enhance profit margins while positioning the company to capture greater market share in production-level AI deployments.
The Meta partnership represents the more substantial catalyst. This agreement, combined with existing commitments from Microsoft and additional partners, has elevated Nebius’s cumulative contracted backlog to approximately $50 billion. Such figures typically capture significant attention from institutional investors.
Goldman Sachs responded swiftly by increasing its price objective for NBIS following the Meta announcement. BWS Financial and DA Davidson maintain $200 price targets with Buy recommendations. Cantor Fitzgerald launched coverage with an Overweight stance, though using a more cautious $129 target. Overall analyst consensus stands at “Moderate Buy” with a mean price target of $154.75.
Institutional capital has been flowing into the name. Millennium Management established a fresh position valued at approximately $11.6 million during Q1. UBS contributed roughly $9 million in new holdings. Oppenheimer expanded its stake by 90.9% in Q4. Aggregate institutional ownership currently represents about 21.9% of shares outstanding.
Understanding the Contracted Backlog Narrative
The nearly $50 billion contracted backlog forms the foundation of the bullish investment thesis. Long-term agreements with technology giants including Meta and Microsoft provide revenue predictability extending through 2026, when management projects revenue between $3.0 and $3.4 billion.
This level of forward revenue visibility remains uncommon in the sector, explaining why momentum-focused investors have driven shares to record levels.
Potential Headwinds and Concerns
Several challenges deserve consideration. Operating cash flow for fiscal year 2025 totaled approximately $402 million — however, this figure incorporated nearly $983 million from customer advance payments. Excluding these advances reveals a more modest cash generation profile.
Company leadership has acknowledged that projected contracted cash flows will satisfy only approximately 60% of anticipated 2026 capital expenditure needs. This funding shortfall raises legitimate concerns regarding possible shareholder dilution or additional financing requirements.
Insider transaction activity has been notable. Chief Technology Officer Danila Shtan divested over 13,000 shares in late March. Insider Andrey Korolenko sold more than 31,000 shares during early April. Collectively, company insiders have liquidated around 135,622 shares valued at over $15.6 million across the past three months.
The equity also exhibits a beta coefficient of 4.03 — indicating significant volatility in both upward and downward price movements. With projected full-year EPS of -$2.44 and a PE ratio of -120.49, current valuation relies entirely on forward growth expectations.
The company reports Q1 2026 results on May 13. Market participants will closely monitor annual recurring revenue expansion, progress updates on hyperscaler infrastructure deployments, and preliminary indicators regarding Eigen AI integration execution.


